PD-1 blockade plus cisplatin-based chemotherapy in patients with small cell/neuroendocrine bladder and prostate cancers

By sjmartinez • November 14, 2024

Gu Y, Ly A, Rodriguez S, Zhang H, Kim J, Mao Z, Sachdeva A, Zomorodian N, Pellegrini M, Li G, Liu S, Drakaki A, Rettig MB, Chin AI. PD-1 blockade plus cisplatin-based chemotherapy in patients with small cell/neuroendocrine bladder and prostate cancers. Cell Rep Med. 2024 Nov 6:101824. doi: 10.1016/j.xcrm.2024.101824. Epub ahead of print. PMID: 39536751.

Tags: Clinical Trial, Dermatology, Hematology/Oncology, immunochemotherapy, neuroendocrine prostate cancer, PD-1 blockade, Publications, single-cell sequencing, small cell bladder cancer, small cell cancers, T cell receptor sequencing, Veterans Administration

Related Posts

The Epidemiology of Atopic Dermatitis Among Adults and Adolescents with Alopecia Areata in the United States

Bunick CG, Armstrong AW, Grada A, Soliman AM, Li C, Bristow CC, Khan IA, Lipiszko D, Silverberg JI, Issa NT, Mostaghimi A. The Epidemiology of[...]

Dynamics of Th1/Th17 responses and antimicrobial pathways in leprosy skin lesions

Andrade PR, Ma F, Lu J, de Anda J, Lee EY, Agak GW, Dobry CJ, de Andrade Silva BJ, Teles RM, Mansky LA, Perrie J,[...]

Mammary tissue microbiome analysis in PyMT mice reveals Methylobacteria as a commensal organism with potential therapeutic applications

Chan AA, Caron C, Navarrete M, Lee CK, Noguti J, Bui JD, Lee DJ. Mammary tissue microbiome analysis in PyMT mice reveals Methylobacteria as a[...]